Molecular Targets in Hepatocarcinogenesis and Implications for Therapy

Area of Science:

• Hepatology and Cancer Biology
• Immunology and Molecular Biology

Background:

• Hepatocarcinogenesis involves complex pathways like telomere dysfunction, cell cycle regulation, WNT/β-catenin signaling, oxidative stress, and AKT/mTOR signaling following liver injury.
• Persistent cycles of gene mutation, oxidative stress, and inflammation drive liver cell proliferation, apoptosis, and immune dysregulation via cytokine signaling (e.g., IL-1β, TGF-β) and pathways like NF-κB.

Purpose of the Study:

• To review the intricate roles of hepatocarcinogenesis and the immune system in the development of liver cancer.
• To provide a comprehensive overview of recent basic and clinical research in the field.

Main Methods:

• Literature review synthesizing existing studies on hepatocarcinogenesis and liver cancer immunology.
• Analysis of molecular pathways, signaling cascades, and cytokine involvement in cancer progression.

Main Results:

• Identified key molecular pathways and cellular processes contributing to liver cancer initiation and progression.
• Highlighted the critical role of immune system modulation and escape mechanisms in liver cancer development.

Conclusions:

• Understanding the interplay between hepatocarcinogenesis and immune evasion is vital for developing novel therapeutic strategies.
• This review establishes a foundation for identifying new anti-carcinogenesis targets for liver cancer treatment interventions.